Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Albemarle Corporation ALB

Basic Materials — Specialty Chemicals
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index ,
Growth Flags show if company had growth for consecutive years

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
7.38
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell 2 — — — 2 1 — 1 — — — —
Insider Ownership
0.25%

Capital & Financial Ratios

Market Cap
13,590.00
Revenue
5,907.90
Net Income
278.49
Free Cash Flow
1,351.43
Net Debt
245.10
Current Ratio
2.09
Debt/Equity
0.18
P/E ratio
231.06
P/S ratio
2.21
P/B ratio
1.58
Past 5Y EPS Growth
16.09%
This Y EPS Growth
1,552.94%
Next Y EPS Growth
(14.56%)
Next 5Y EPS Growth
(6.21%)
in millions of $

Dividends

Payout Ratio
0.05
Annual Dividend Rate
1.60
Annual Dividend Yield
1.41%
total individual payouts
2028 ‡‡‡‡‡
2027 ‡‡‡‡‡
2026 1.62
—
—
—
2025 1.62
—
—
—
—
2024 1.61
—
—
—
—
2023 1.60
—
—
—
—
2022 1.58
—
—
—
—
2021 1.56
—
—
—
—
2020 1.54
—
—
—
—
2019 1.47
—
—
—
—
2018 1.34
—
—
—
—
2017 1.28
—
—
—
—
2016 1.22
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 889.90 1,192.23 1,618.00 1,631.69
Receivables 1,722.26 980.59 698.61 727.68
Inventory 2,161.29 1,502.53 1,179.27 1,384.56
Other 443.48 166.92 512.26 200.28
5,216.92 3,842.26 4,008.14 3,944.20
2023 2024 2025 Q'26
Payables 2,088.05 943.89 913.53 1,115.65
ST’ Debt 625.76 398.02 74.08 74.68
Other — — 191.75 —
3,560.46 1,966.46 1,798.04 1,891.10
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡ ‡‡‡ ‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 1,428.73 1,743.31 — —
—
’25 1,076.88 1,329.99 1,307.83 1,428.03
5,142.73
’24 1,360.74 1,430.39 1,354.69 1,231.71
5,377.53
’23 2,580.25 2,370.19 2,310.60 2,356.17
9,617.20
’22 1,127.73 1,479.59 2,091.81 2,620.98
7,320.10
’21 829.29 773.90 830.57 894.20
3,327.96
’20 738.85 764.05 746.87 879.15
3,128.91
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 346.24 710.00 — —
—
’25 547.21 (9.03) 355.60 388.49
1,282.27
’24 97.95 367.19 227.11 (4.38)
687.88
’23 720.98 73.71 628.85 (96.96)
1,326.58
’22 206.18 (145.86) 895.29 952.25
1,907.85
’21 157.95 227.90 104.73 (146.33)
344.26
’20 155.05 52.86 253.80 337.20
798.91
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 247.57 638.27 — —
—
’25 364.58 (104.90) 225.34 240.26
725.28
’24 (481.37) (88.08) (76.02) (318.09)
(963.55)
’23 305.37 (429.98) 82.96 (786.31)
(827.96)
’22 (25.52) (416.77) 581.96 506.54
646.20
’21 (21.73) 10.67 (151.09) (447.26)
(609.41)
’20 (59.47) (151.60) 51.42 108.09
(51.56)
in millions of $

EPS

Mar Jun Sep Dec Year
’26 2.34 3.52 — —
—
’25 0.00 (0.16) (1.72) (3.87)
(5.76)
’24 (0.08) (1.96) (9.45) 0.29
(11.20)
’23 10.51 5.52 2.57 (5.26)
13.36
’22 2.15 3.46 7.61 9.60
22.84
’21 0.84 3.62 (3.36) (0.03)
1.06
’20 1.01 0.80 0.92 0.79
3.52

Target Price Range

High
‡‡‡‡‡
‡‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡‡

Recommendation Rating

1.8
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 169.93 112.00 71.97 49.43 — — —
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 334.55 293.01 149.61 152.08 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7,400 9,000 8,300 7,800 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.99 1.07 0.65 0.66 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7,320.10 9,617.20 5,377.53 5,142.73 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 42.00% 12.33% 1.16% 13.00% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,433.44 246.74 (1,763.82) (552.07) — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 33.24% 2.57% (32.80%) (10.74%) ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,815.13 1,670.54 (1,135.48) (465.21) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 300.84 429.94 588.64 839.75 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 62.50 81.98 45.76 43.71 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 22.97 13.41 (11.20) (5.76) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 16.29 11.31 5.85 10.90 — — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (10.77) (18.37) (14.05) (4.73) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.52 (7.06) (8.20) 6.16 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 69.94 82.38 86.79 83.13 — — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 117.12 117.32 117.52 117.66 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.34 10.94 0.00 0.00 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.43 1.79 1.88 3.24 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.07 1.78 1.27 2.21 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.67 2.13 2.31 3.54 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 41.54 (24.77) (12.91) 25.12 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,907.85 1,326.58 687.88 1,282.27 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1,261.65) (2,154.54) (1,651.43) (556.99) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 646.20 (827.96) (963.55) 725.28 — — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,445.90 1,656.46 1,875.80 2,210.10 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,217.10 4,166.76 3,516.17 3,193.54 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,717.96 3,276.86 2,323.94 1,575.54 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8,190.85 9,665.10 10,199.69 9,781.46 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 20.35% 9.33% (7.55%) (4.11%) — — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 15.58% 1.22% (8.87%) (2.02%) — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 38.44% 17.62% (14.93%) (8.73%) — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Albemarle Corporation (ALB), a lithium giant riding the EV rollercoaster, soared to $9.62 billion in revenue and $2.82 billion in profits by 2023 amid skyrocketing battery demand, only to crater in 2024 with a 44% revenue plunge to $5.38 billion and a $1.14 billion loss as lithium prices collapsed from $80,000 to under $10,000 per ton. Gross margins evaporated from 42% to 1.2%, free cash flow flipped negative, and ROE swung from 38% to deep red—exposing the brutal cyclicality of commodity plays. Yet analysts forecast a rebound: revenues stabilizing in 2025 before climbing 12-20% through 2027, FCF turning positive at $725 million, and EPS hitting $6.57 by 2028, fueled by EV adoption projected at 20-30% of global sales.

The balance sheet holds firm with $10.2 billion in equity and moderate $2.32 billion net debt, while valuations scream bargain—PS at 1.9x, PB at 1.3x, and EV/Sales at 2.3x versus historical averages. Stock resilience above 2025 lows, despite lagging the downturn, hints at market bets on recovery, with average analyst targets implying 20% upside (highs at 38%). Insiders are mum on buys but not dumping, signaling caution amid U.S. policy tailwinds like the Inflation Reduction Act and strategic acquisitions.

Is ALB a screaming buy or value trap? Lithium’s path to $15,000/ton consensus could deliver 50%+ returns by 2028 for patient holders, but oversupply, geopolitics, and EV slowdowns loom large. Dive into the full analysis for capex trends, ROIC pitfalls, and the Q1 2026 earnings trigger that could ignite the next leg up.

Read full commentary →

Albemarle Corporation (ALB) Latest News

News by impact score

Fine-tune

18 Sep

3 , 2:13 PM
Analysts cut Albemarle fair value estimates after lowering lithium price assumptions. Lowered lithium assumptions reduce Albemarle valuation targets and may pressure near-term stock performance.

16 Sep

4 , 8:00 AM
Albemarle pursues lithium capacity expansion to support higher sales volumes amid rising demand. Lithium expansion plans directly affect Albemarle's production capacity and positioning in battery materials.

9 Sep

4 247wallst.com, 11:45 AM
China retains battery production dominance as $500 million investments prove insufficient to overcome time constraints, limiting Albemarle's ability to gain ground in the sector. China's battery grip despite funding restricts Albemarle's competitive trajectory and investor outlook.

5 Sep

3 , 12:00 PM
Albemarle names its next CEO to lead amid a $250 million company valuation swing for every dollar change in a key pricing factor. New Albemarle leadership faces inherited commodity-linked volatility that can moderately affect financial results and investor views.

4 Sep

4 , 7:43 AM
Albemarle's incoming CEO takes over amid conditions where every one-dollar shift creates a $250 million impact on the company. New leadership confronts major earnings volatility from per-dollar swings that could reshape Albemarle's trajectory and investor sentiment.

3 Sep

3 , 8:00 AM
Albemarle Corporation announces CEO succession plan. CEO succession introduces potential shifts in corporate strategy and leadership direction.

20 Aug

3 , 8:24 AM
Albemarle holds substantial cash reserves that could fund higher dividends or share buybacks to boost shareholder returns. Cash deployment for shareholder returns may moderately influence Albemarle's financial performance and investor sentiment without altering core operations.

19 Aug

3 , 12:34 AM
Albemarle stock appears below fair value after a 67% gain. Valuation assessment after a large share price increase can shift near-term investor sentiment and trading volume for Albemarle.

18 Aug

4 , 1:15 PM
Albemarle posts profit rebound and raises 2026 outlook, signaling stronger financial recovery and improved prospects for shareholders. Profit rebound combined with raised 2026 guidance signals major positive shift in Albemarle's financial trajectory and market positioning.

17 Aug

3 , 8:00 PM
Albemarle Corporation advances North America’s only cesium project toward production. Progress on the cesium project may moderately boost Albemarle’s specialty materials revenue and market position.

13 Aug

3 transcript www.fool.com, 10:10 AM
Albemarle (ALB) released Q2 2026 earnings call transcript with management discussing quarterly financial results, operational updates and forward outlook. Earnings call provides quarterly results and guidance that can shift near-term sentiment but rarely alters long-term company trajectory.

7 Aug

3 transcript www.marketbeat.com, 5:04 PM
Albemarle reported Q2 results with updates on lithium production volumes, pricing trends, revenue and EPS figures, segment performance, cost management, and forward guidance on capacity expansions amid EV battery demand shifts. Q2 earnings and guidance directly inform near-term financial trajectory and lithium market positioning without indicating structural breaks.

3 , 10:00 AM
Albemarle's Q2 earnings call highlighted storage demand while signaling pressure expected in Q3. Q2 storage demand noted but Q3 pressure signals moderate effect on near-term performance.

6 Aug

4 , 4:48 PM
Albemarle stock jumps 8% after lithium pricing triples EBITDA. Lithium pricing surge triples EBITDA and lifts stock 8 percent, signaling major earnings growth ahead.

4 , 3:05 PM
Albemarle Corp reported strong demand and record EBITDA for Q2 2026. Record EBITDA with strong demand signals major positive shifts in financial performance and market trajectory.

3 transcript app.moby.co, 8:30 AM
Albemarle Corporation held its Q2 2026 earnings call covering financial results, operational updates and forward outlook. Quarterly earnings updates typically produce moderate short-term effects on valuation and sentiment without altering long-term strategy.

3 , 8:22 AM
Albemarle reported Q2 earnings that beat estimates, driven by strong lithium pricing. Q2 earnings beat signals positive lithium pricing trends that moderately support Albemarle's near-term financial results.

5 Aug

4 , 5:06 PM
Albemarle Corporation reported a 3,300% earnings increase driven by commodity price gains. Exceptional earnings surge signals major positive shift in financial performance and investor outlook.

4 , 4:15 PM
Albemarle Corporation released its second quarter 2026 financial results. Quarterly results deliver core financial data that can shift valuation and investor outlook.

3 , 6:00 PM
Albemarle reported Q2 earnings with analysis of key metrics tied to its lithium and chemicals operations. Q2 earnings metrics offer moderate insight into Albemarle's financial performance without indicating major strategic shifts.

3 , 4:13 AM
Albemarle earnings hopes are building while the stock trades 35% below fair value. Rising earnings expectations and valuation gap point to moderate effects on Albemarle stock trajectory and sentiment.

4 Aug

3 , 11:10 AM
Bartolomeo’s appointment to Albemarle’s board raises questions about potential shifts in the company’s energy storage strategy. Board appointment may moderately affect Albemarle’s strategic direction in energy storage.

3 , 7:47 AM
Strategies for trading Albemarle Corporation stock are outlined ahead of the Q2 earnings release. Q2 earnings release may moderately influence Albemarle financial results and stock trajectory.

29 Jul

3 , 10:00 AM
Albemarle earnings are projected to grow, raising the question of whether the stock represents a buy. Expected Albemarle earnings growth may moderately influence stock valuation and investor interest without altering core trajectory.

17 Jul

3 , 11:11 AM
Rising earnings estimates for Albemarle prompt debate on whether its lithium strategy reflects management discipline or exposure to market cycles. Rising earnings estimates may shift sentiment around Albemarle's lithium operations but do not signal structural changes.

16 Jul

4 , 8:00 PM
Albemarle Corporation stands at the center of the leading commodity narrative of the year that Wall Street continues to overlook. Unrecognized commodity developments position Albemarle for major shifts in market trajectory and investor sentiment.

3 , 10:02 AM
DuPont launches end-to-end direct lithium extraction portfolio. DuPont entry expands direct lithium extraction competition and may moderately pressure Albemarle positioning.

3 , 8:21 AM
Albemarle Corporation pursues expansion actions that could boost future sales volumes. Expansion initiatives may moderately affect Albemarle sales volumes and trajectory.

10 Jul

3 , 6:30 AM
Albemarle (ALB) named Bull of the Day with positive analyst coverage highlighting growth prospects in lithium and specialty chemicals. Bull of the Day designation provides moderate short-term sentiment boost but does not signal major strategic or operational shifts.

8 Jul

3 , 8:11 AM
Albemarle (ALB) may be 39% undervalued ahead of earnings release, supported by cost-saving measures. Valuation assessment tied to earnings and cost cuts can moderately shift near-term investor sentiment for Albemarle.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us